FORA Capital, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
FORA Capital, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2022$210,000
-29.3%
3,185
+14.9%
0.04%
-65.2%
Q4 2021$297,000
-99.5%
2,773
+287.8%
0.12%
+858.3%
Q2 2021$63,000,000
-86.6%
715
-82.9%
0.01%
-83.3%
Q4 2020$469,000,000
+110.3%
4,185
+74.2%
0.07%
-50.7%
Q3 2020$223,000,000
+8.3%
2,403
-9.0%
0.15%
+105.6%
Q2 2020$206,000,000
+202.9%
2,640
+211.3%
0.07%
+914.3%
Q4 2019$68,000,0008480.01%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders